These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 30986311)

  • 1. Pain Intensity, Pressure Pain Hypersensitivity, Central Sensitization, and Pain Catastrophizing Related to Vascular Alterations in Raynaud's Phenomenon: A Preliminary Case-Control Study.
    Tapia-Haro RM; Guisado-Barrilao R; García-Ríos MDC; Raya-Álvarez E; Pérez-Mármol JM; Aguilar-Ferrándiz ME
    Pain Med; 2020 May; 21(5):891-901. PubMed ID: 30986311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laser Doppler-recorded venoarteriolar reflex in Raynaud's phenomenon.
    Stoyneva Z
    Auton Neurosci; 2004 Nov; 116(1-2):62-8. PubMed ID: 15556839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sleep, Pain Catastrophizing, and Central Sensitization in Knee Osteoarthritis Patients With and Without Insomnia.
    Campbell CM; Buenaver LF; Finan P; Bounds SC; Redding M; McCauley L; Robinson M; Edwards RR; Smith MT
    Arthritis Care Res (Hoboken); 2015 Oct; 67(10):1387-96. PubMed ID: 26041510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors Influencing Raynaud Condition Score Diary Outcomes in Systemic Sclerosis.
    Pauling JD; Reilly E; Smith T; Frech TM
    J Rheumatol; 2019 Oct; 46(10):1326-1334. PubMed ID: 30824643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unraveling Self-Reported Signs of Central Sensitization in Breast Cancer Survivors with Upper Limb Pain: Prevalence Rate and Contributing Factors.
    De Groef A; Meeus M; De Vrieze T; Vos L; Van Kampen M; Geraerts I; Devoogdt N
    Pain Physician; 2018 May; 21(3):E247-E256. PubMed ID: 29871380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma urotensin II levels in primary Raynaud's phenomenon and systemic sclerosis.
    Gözel N; Karataş A; Yardım M; Kınacı MS; Ulu R; Demircan F; Kılınç F; Öz B; Dönder E; Aydın S; Koca SS
    Turk J Med Sci; 2017 Dec; 47(6):1687-1692. PubMed ID: 29306224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Digital vascular responses and serum endothelin-1 concentrations in primary and secondary Raynaud's phenomenon.
    Smyth AE; Bell AL; Bruce IN; McGrann S; Allen JA
    Ann Rheum Dis; 2000 Nov; 59(11):870-4. PubMed ID: 11053063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemorheological profile in primary and secondary Raynaud's phenomenon. Influence of microangiopathy.
    Vayá A; Alis R; Romagnoli M; Todolí J; Calvo J; Ricart JM
    Clin Hemorheol Microcirc; 2014; 56(3):259-64. PubMed ID: 23609604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A thermal vascular test for distinguishing between patients with Raynaud's phenomenon and healthy controls. Raynaud's Treatment Study Investigators.
    Jennings JR; Maricq HR; Canner J; Thompson B; Freedman RR; Wise R; Kaufmann PG
    Health Psychol; 1999 Jul; 18(4):421-6. PubMed ID: 10431945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular responses evoked by mild cool stimuli in primary Raynaud's disease: the role of endothelin.
    Edwards CM; Marshall JM; Pugh M
    Clin Sci (Lond); 1999 Jun; 96(6):577-88. PubMed ID: 10334963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microvascular reactivity during sympathetic stimulations in Raynaud's phenomenon.
    Stoyneva ZB; Dermendjiev SM; Medjidieva DG; Vodenicharov VE
    Int Angiol; 2016 Dec; 35(6):593-598. PubMed ID: 27015234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cutaneous vasoconstrictor response to venous stasis is normal in subjects with primary Raynaud's disease.
    Edwards CM; Marshall JM; Pugh M
    Clin Auton Res; 1999 Oct; 9(5):255-62. PubMed ID: 10580877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients With Chronic Spinal Pain Benefit From Pain Neuroscience Education Regardless the Self-Reported Signs of Central Sensitization: Secondary Analysis of a Randomized Controlled Multicenter Trial.
    Malfliet A; Kregel J; Meeus M; Danneels L; Cagnie B; Roussel N; Nijs J
    PM R; 2018 Dec; 10(12):1330-1343.e1. PubMed ID: 29753112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired transient vasodilation and increased vasoconstriction to digital local cooling in primary Raynaud's phenomenon.
    Roustit M; Blaise S; Millet C; Cracowski JL
    Am J Physiol Heart Circ Physiol; 2011 Aug; 301(2):H324-30. PubMed ID: 21572005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased asymmetric dimethylarginine and endothelin 1 levels in secondary Raynaud's phenomenon: implications for vascular dysfunction and progression of disease.
    Rajagopalan S; Pfenninger D; Kehrer C; Chakrabarti A; Somers E; Pavlic R; Mukherjee D; Brook R; D'Alecy LG; Kaplan MJ
    Arthritis Rheum; 2003 Jul; 48(7):1992-2000. PubMed ID: 12847693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The moderating effects of pain catastrophizing on the relationship between illness perceptions and self-reported signs of central sensitization in patients with persistent pain.
    Wijma AJ; Bults R; Nijs J; Paul van Wilgen C
    Int J Rehabil Res; 2020 Dec; 43(4):347-354. PubMed ID: 32909989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Digital blood flow response to body warming, cooling, and rewarming in patients with Raynaud's phenomenon.
    Lau CS; Khan F; Brown R; McCallum P; Belch JJ
    Angiology; 1995 Jan; 46(1):1-10. PubMed ID: 7818151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of soluble adhesion molecules in primary Raynaud's phenomenon and in Raynaud's phenomenon secondary to connective tissue diseases.
    Brevetti G; De Caterina M; Martone VD; Corrado S; Silvestro A; Spadaro G; Scopacasa F
    Int J Clin Lab Res; 2000; 30(2):75-81. PubMed ID: 11043500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral activation and catastrophizing during pain anticipation in patients with fibromyalgia.
    Burgmer M; Petzke F; Giesecke T; Gaubitz M; Heuft G; Pfleiderer B
    Psychosom Med; 2011; 73(9):751-9. PubMed ID: 22048836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Raynaud's phenomenon-an update on diagnosis, classification and management.
    Pauling JD; Hughes M; Pope JE
    Clin Rheumatol; 2019 Dec; 38(12):3317-3330. PubMed ID: 31420815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.